Better health is associated with a higher risk of heart disease.

Published Date: 17 Feb 2023

UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...

Read Full News

Latest News

More Costly, Polarized Dermatoscope Results Compared to Nonpolarized Dermatoscope

More Costly, Polarized Dermatoscope Results Compared to Nonpolarized Dermatoscope

Session on the Skin Microbiome and Atopic Dermatitis Presented at 2025 SDPA Fall Conference

Session on the Skin Microbiome and Atopic Dermatitis Presented at 2025 SDPA Fall Conference

Difficult Cases and Red Flags in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD

In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.

8 Dermatology Headlines You Missed in November 2025

8 Dermatology Headlines You Missed in November 2025

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

Todays Updates

Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results Louie Pasculli

Merck's MK-2214 shows promise in early Alzheimer’s trials, earning FDA fast-track status for its safety and potential efficacy in slowing disease progression.

Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles Marco Meglio

New STIRUS data unveiled at AES 2025 demonstrate meaningful real-world reductions in seizures, status epilepticus, and healthcare needs with stiripentol in Dravet syndrome.

NBI-827104’s Phase 2 Disappointment Highlight Therapeutic Needs for Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep Marco Meglio

New findings reveal the challenges of treating pediatric epileptic encephalopathy with NBI-827104, highlighting the need for effective therapies.

5 FDA Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

Todays Updates

Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results Louie Pasculli

Merck's MK-2214 shows promise in early Alzheimer’s trials, earning FDA fast-track status for its safety and potential efficacy in slowing disease progression.

Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles Marco Meglio

New STIRUS data unveiled at AES 2025 demonstrate meaningful real-world reductions in seizures, status epilepticus, and healthcare needs with stiripentol in Dravet syndrome.

NBI-827104’s Phase 2 Disappointment Highlight Therapeutic Needs for Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep Marco Meglio

New findings reveal the challenges of treating pediatric epileptic encephalopathy with NBI-827104, highlighting the need for effective therapies.

5 FDA Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

Latest News

More Costly, Polarized Dermatoscope Results Compared to Nonpolarized Dermatoscope

Session on the Skin Microbiome and Atopic Dermatitis Presented at 2025 SDPA Fall Conference

In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.

8 Dermatology Headlines You Missed in November 2025

Antibiotic Exposure Linked to Increased Risk of Biologic Discontinuation in Psoriasis

sNDA for Ameluz-PDT as a Treatment for Superficial Basal Cell Carcinoma Submitted to FDA

News All Time

Skin of Color Savvy: Hair-Care Challenges in Dermatology, With Amy McMichael, MD, and Kayla Taylor, MD Amy McMichael, MD, Kayla Taylor, MD

This November 18 episode explores early detection, diagnosis, and management of scarring alopecias and hair-care–related hair loss in patients of color.

Non-Steroidal Topicals: A Game-Changer for Pediatric Atopic Dermatitis, With Emily Becker, MD Emily Becker, MD

Becker recapped hot topics of discussion during a recent HCPLive clinical forum.

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

AI’s Use in Non-Patient-Facing Dermatology Spaces, With Joseph Gatti, DMSc, MPAS, MBA, PA-C

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Atopic Diseases Significantly Raise the Risk of Post-Surgical Complications

Discussing Zasocitinib and Other TYK2 Inhibitors for Psoriasis, With Ronald Vender, MD Ronald Vender, MD

After his sessions on TYK2 Inhibitors for psoriasis and on palmoplantar pustulosis, Vender discussed several key insights in this interview.

Progress with Emerging TYK2 Inhibitors for Psoriasis, With Benjamin Lockshin, MD Benjamin Lockshin, MD, FAAD

Benjamin Locksin speaks in this interview about his session titled ‘Encapsulating Progress With New and Emerging TYK2 Inhibitors for Psoriasis.’

Discussing Findings on Secukinumab (Cosentyx) Efficacy Over 4 Years in HS, With Martina Porter, MD Martina Porter, MD

This interview highlights long-term, phase 3 data from the SUNSHINE and SUNRISE core and extension trials on secukinumab for hidradenitis suppurativa.

Tapinarof Shows Early, Sustained Benefits in Pediatric Atopic Dermatitis, With Druhan Howell, MD Druhan Howell, MD

At ACAAI 2025, Howell discussed sub-analytical data showing early itch and skin improvements with tapinarof cream in children with AD aged 2–17 years.

ARCADIA LTE: Long-term Nemolizumab Effective in Adolescents with Atopic Dermatitis

ARCADIA LTE: Long-term Nemolizumab Effective in Adolescents with Atopic Dermatitis

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

Skin of Color Savvy: A New Podcast Episode Following SOCS Media Day

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

The HCPFive: Top News for Healthcare Providers from the Week of 11/16

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Durability of Biologics for Psoriasis Compared, Adjusted for Drug Switching Over Time

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Mid Trial Update Released on Baricitinib for Frontal Fibrosing Alopecia

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

Rezpegaldesleukin Shows Strong Phase 2b Results for Atopic Dermatitis, Asthma

New 'heart percentile' calculator helps young adults grasp their long-term risk

A new Northwestern Medicine study introduces a first-of-its-kind online calculator that uses percentiles to help younger adults forecast and understand their risk of a heart event over the next 30 years. With rates of obesity, ...

Chronic pain may increase risk of high blood pressure in adults

Chronic pain in adults may increase their risk of high blood pressure, and the location and extent of pain and if they also had depression were contributing factors, according to new research published today in Hypertension.

Recommended News For You

Resection for Early Liver Cancer Tied to Improved Survival.

Dementia-like protein buildup found in pancreas cells before cancer develops

Study identifies new approach to protect the brain during radiation therapy

Pancreatic cancer RNA vaccine shows durable T cell immunity

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor

AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

Recommended Articles For You

The Importance of Iron Rich Foods in Preventing and Treating Anemia  

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice 

The Science Behind Thrombolytic Drugs and Their Benefits  

Molecular & Genetic Oncology: Emerging Frontiers in 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.

2.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

3.

Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation

4.

Appropriate New Monoclonal for Immunocompromised Individuals to Prevent COVID-19.

5.

Can certain food cravings predict a cancer diagnosis up to three months before other symptoms appear?

1.

A Closer Look at MCV Modules: Features, Functions, and Benefits 

2.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

3.

HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review

4.

Navigating the Complexities of Melanoma Staging: A Comprehensive Guide

5.

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XV

2.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

3.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

4.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

5.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot